Apex Science & Engineering Financing Cash Flow
The Net Financing Cash Flow of Apex Science & Engineering (3052.TW) as of Oct 20, 2026 is -1.57 B TWD. In the previous year, Net Financing Cash Flow was 884.11 M TWD — a change of -277.56% (lower).
Get this data via API
Financial Data API
Financing Cash Flow
-1.57 BTWD
YoY
-277.56%
Last updated:
The Apex Science & Engineering Financing Cash Flow history
3 Years
10 Years
25 Years
Max
| YEAR | Financing Cash Flow | YoY |
|---|---|---|
| -1.57 BTWD | -277.56% | |
| 884.11 MTWD | +247.59% | |
| 254.36 MTWD | +112.83% | |
| 119.51 MTWD | +9.11% | |
| 109.54 MTWD | -115.52% | |
| -705.93 MTWD | -73.36% | |
| -2.65 BTWD | -217.78% | |
| 2.25 BTWD | -243.48% | |
| -1.57 BTWD | -278.49% | |
| 878.64 MTWD | -26.18% | |
| 1.19 BTWD | +272.07% | |
| 319.90 MTWD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Apex Science & Engineering Stock analysis
Frequently Asked Questions about Apex Science & Engineering stock
Net Financing Cash Flow of Apex Science & Engineering is -1.57 B TWD in 2025.
Net Financing Cash Flow of Apex Science & Engineering changed from 884.11 M TWD to -1.57 B TWD, representing a -277.56% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Net Financing Cash Flow Apex Science & Engineering since 2006 – with annual values, charts, and detailed analysis.
Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.
Net Financing Cash Flow's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Apex Science & Engineering historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — Apex Science & Engineering
All Key Metrics — Apex Science & Engineering
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth